drugset / Trial / NCT03681574

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

NCT03681574

Phase 4 Completed 135 enrolled Hospital Infantil Albert Sabin
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a clinical trial, prospective, randomized and double-blinded. Placebo, Gabapentin syrup at 15 mg/kg, and Gabapentin syrup at 30 mg/kg were administered to reduce agitation before and after in children submitted procedures (myelogram or lumbar puncture) among 1 and 6 years.

Timeline

Start
2017-07-01
Primary completion
2018-07-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 15 mg/kg Oral
Subject Gabapentin Small molecule 30 mg/kg Oral